Get startedLog in
    Picture of Sandoz AG logo

    SDZ — Sandoz AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Sandoz Confirms European Commission Approval For Ranluspec

    Picture of Sandoz AG logoSandoz AG
    23/02/2026 10:02
    Feb 23 (Reuters) - SANDOZ GROUP AG SDZ.S:

SANDOZ CONFIRMS EUROPEAN COMMISSION APPROVAL FOR RANLUSPEC® (RANIBIZUMAB), FURTHER STRENGTHENING OVERALL BIOSIMILARS LEADERSHIP AND POSITION IN OPHTHALMOLOGY

SANDOZ GROUP AG - RANLUSPEC LAUNCH EXPECTED SECOND HALF OF 2026

SANDOZ GROUP AG - HOLDS EXCLUSIVE RIGHTS FOR RANLUSPEC IN EU

Source text: ID:nEQ27xjQfa

Further company coverage: SDZ.S

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Sandoz AG

    See all news